Search
Best results in : Research Potential Pokaż wszystkie wyniki (2)
Search results for: NSCLC
-
Zespół Katedry Rachunku Prawdopodobieństwa i Biomatematyki
Research Potential* modele ryzyka i ich zastosowania * probabilistyczne i grafowe metody w biologii * stochastyczne równania różniczkowe * statystyczna analiza danych * teoria grafów * teoria i zastosowania stochastycznych układów dynamicznych w biologii i medycynie
-
Katedra Technologii Leków i Biochemii
Research PotentialRacjonalne projektowanie, synteza i badanie właściwości biologicznych nowych związków o działaniu przeciwnowotworowym lub przeciwgrzybowym
Other results Pokaż wszystkie wyniki (7)
Search results for: NSCLC
-
8-Oxoguanine incision activity is impaired in lung tissues of NSCLC patients with the polymorphism of OGG1 and XRCC1 genes
Publication -
The analysis of the expression of hTERT in anthraquinone-treated NSCLC cells
Open Research DataThe datasets showcase an analysis of hTERT relative gene expression in NSCLC cells treated with anthraquinone, quantified as fold change compared to DMSO-treated control cells, using the comparative CT method.
-
Antiproliferative activity of anthraquinones determined by clonogenic assay
Open Research DataThe data contains the colony formation analysis in A549, H460 and H226 cells after exposure to TXT2 and TXT4. DMSO was used as a negative control.
-
Result of the 6-min walk test is an independent prognostic factor of surgically treated non-small-cell lung cancer
PublicationPathological tumour, node and metastasis (TNM) stage remains the most significant prognostic factor of non-small-cell lung cancer (NSCLC). Meanwhile, age, gender, pulmonary function tests, the extent of surgical resection and the presence of concomitant diseases are commonly used to complete the prognostic profile of the patient with early stage of NSCLC. The aim of this study is to assess how the result of a 6-min walk test (6MWT)...
-
9,10-Dioxoanthracenyldithiocarbamates effectively inhibit the proliferation of non-small cell lung cancer by targeting multiple protein tyrosine kinases
PublicationAnthraquinones have attracted considerable interest in the realm of cancer treatment owing to their potent anticancer properties. This study evaluates the potential of a series of new anthraquinone derivatives as anticancer agents for non-small-cell lung cancer (NSCLC). The compounds were subjected to a range of tests to assess their cytotoxic and apoptotic properties, ability to inhibit colony formation, pro-DNA damage functions,...